Akoya Biosciences, Inc. (AKYA) Q3 2023 Earnings Call Transcript


Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET

Company Participants

Priyam Shah – Head of Investor Relations

Brian McKelligon – Chief Executive Officer

Johnny Ek – Chief Financial Officer

Conference Call Participants

Edmund Tu – Morgan Stanley

Kyle Mikson – Canaccord Genuity

Timothy Chiang – Capital One

Mason Carrico – Stephens Inc.

Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Akoya Biosciences Incorporated Third Quarter 2023 Earnings Conference Call. [Operator Instructions]

At this time, I’d like to turn the conference over to Mr. Priyam Shah. Mr. Shah, you may begin.

Priyam Shah

Thank you, operator, and thank you to everyone who is joining us today on this call. I’m Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer; and Johnny Ek, Chief Financial Officer.

Earlier today, Akoya released financial results for the third quarter ended September 30, 2023. A copy of the press release is available on the company’s website. Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of Federal Securities Laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with the Akoya’s business, please refer to the risks identified in our filings with the US Securities and Exchange Commission, including in the Risk Factors section of our annual report on



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *